
Portfolio
Transforming Cancer Diagnostics: How Better Medicine’s AI Is Changing the Game with Soulmates Ventures as Lead Investor
Soulmates Ventures leads a €1M pre-seed investment in Better Medicine, the Estonian healthtech behind the world’s first CE-certified AI tool for kidney cancer detection. With total funding nearing €6M, the company is accelerating its European rollout, preparing for FDA clearance, and expanding its AI platform to transform global cancer diagnostics.